347 related articles for article (PubMed ID: 22459264)
1. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S
J Psychiatr Res; 2012 Jun; 46(6):716-23. PubMed ID: 22459264
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O;
Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383
[TBL] [Abstract][Full Text] [Related]
3. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
Savaskan E; Mueller H; Hoerr R; von Gunten A; Gauthier S
Int Psychogeriatr; 2018 Mar; 30(3):285-293. PubMed ID: 28931444
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
Napryeyenko O; Borzenko I;
Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.
Scripnikov A; Khomenko A; Napryeyenko O;
Wien Med Wochenschr; 2007; 157(13-14):295-300. PubMed ID: 17704975
[TBL] [Abstract][Full Text] [Related]
7. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
Ihl R; Tribanek M; Bachinskaya N
J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N;
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1087-95. PubMed ID: 24633934
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF
JAMA; 1997 Oct 22-29; 278(16):1327-32. PubMed ID: 9343463
[TBL] [Abstract][Full Text] [Related]
10. Effects of Ginkgo biloba extract EGb 761 ® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials.
Ihl R
Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():8-14. PubMed ID: 23808613
[TBL] [Abstract][Full Text] [Related]
11. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
Bachinskaya N; Hoerr R; Ihl R
Neuropsychiatr Dis Treat; 2011; 7():209-15. PubMed ID: 21573082
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial.
Ihl R; Tribanek M; Bachinskaya N;
Pharmacopsychiatry; 2012 Mar; 45(2):41-6. PubMed ID: 22086747
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial.
Napryeyenko O; Sonnik G; Tartakovsky I
J Neurol Sci; 2009 Aug; 283(1-2):224-9. PubMed ID: 19286192
[TBL] [Abstract][Full Text] [Related]
14. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Mazza M; Capuano A; Bria P; Mazza S
Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
[TBL] [Abstract][Full Text] [Related]
16. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
Le Bars PL; Kieser M; Itil KZ
Dement Geriatr Cogn Disord; 2000; 11(4):230-7. PubMed ID: 10867450
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Ginkgo biloba extract EGb 761
von Gunten A; Schlaefke S; Überla K
World J Biol Psychiatry; 2016 Dec; 17(8):622-633. PubMed ID: 26223956
[TBL] [Abstract][Full Text] [Related]
18.
Spiegel R; Kalla R; Mantokoudis G; Maire R; Mueller H; Hoerr R; Ihl R
Clin Interv Aging; 2018; 13():1121-1127. PubMed ID: 29942120
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
Mix JA; Crews WD
Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.
Gauthier S; Schlaefke S
Clin Interv Aging; 2014; 9():2065-77. PubMed ID: 25506211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
